FAP-specific PET signaling shows a moderately positive correlation with relative CBV and no correlation with ADC in 13 IDH wildtype glioblastomas.


Journal

European journal of radiology
ISSN: 1872-7727
Titre abrégé: Eur J Radiol
Pays: Ireland
ID NLM: 8106411

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 18 12 2019
revised: 14 02 2020
accepted: 13 04 2020
pubmed: 29 4 2020
medline: 8 1 2021
entrez: 29 4 2020
Statut: ppublish

Résumé

Targeting Fibroblast Activation Protein (FAP) is a new approach for glioblastoma imaging. In a recent pilot study glioblastomas showed elevated tracer uptake with high intratumoral heterogeneity in projection on the corresponding T2w/FLAIR and contrast enhanced MRI lesions. In this study, we correlated FAP-specific signaling with apparent diffusion coefficient (ADC) and relative cerebral blood volume (rCBV) signals in MRI to further characterize the significance of FAP uptake. Clinical PET/CT scans of 13 glioblastoma patients were performed post i. v. administration of FAP-specific PET signals showed a moderately positive correlation with rCBV values which is more pronounced within the T2w/FLAIR lesion (pooled correlation 0,229) than in the contrast enhancing tumor region (pooled correlation 0.09). FAP-specific PET signals showed no correlation with ADC values. The moderately positive correlation of FAP-specific signals with rCBV values in MRI indicates that FAP-signaling is not independent from perfusion, but also does not only reflect intratumoral perfusion differences. The missing correlation of FAP-specific signals with ADC indicates that FAP-specific imaging does not reflect cell density, but the spot-like expression of FAP in glioblastomas. The clinical value of FAP-specific imaging needs further investigation.

Identifiants

pubmed: 32344293
pii: S0720-048X(20)30210-2
doi: 10.1016/j.ejrad.2020.109021
pii:
doi:

Substances chimiques

Gallium Radioisotopes 0
Membrane Proteins 0
Endopeptidases EC 3.4.-
Serine Endopeptidases EC 3.4.21.-
fibroblast activation protein alpha EC 3.4.21.-
Gelatinases EC 3.4.24.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

109021

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Auteurs

Manuel Röhrich (M)

Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Nuclear Medicine, University Hospital Heidelberg, Germany. Electronic address: manuel.roehrich@med.uni-heidelberg.de.

Ralf Floca (R)

Division of Medical Image Computing, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Radiation Oncology, University Hospital Heidelberg, Germany.

Lisa Loi (L)

Division of Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Sebastian Adeberg (S)

Department of Radiation Oncology, University Hospital Heidelberg, Germany.

Paul Windisch (P)

Department of Radiation Oncology, University Hospital Heidelberg, Germany.

Frederik L Giesel (FL)

Department of Nuclear Medicine, University Hospital Heidelberg, Germany.

Clemens Kratochwil (C)

Department of Nuclear Medicine, University Hospital Heidelberg, Germany.

Paul Flechsig (P)

Department of Nuclear Medicine, University Hospital Heidelberg, Germany.

Hendrik Rathke (H)

Department of Nuclear Medicine, University Hospital Heidelberg, Germany.

Thomas Lindner (T)

Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Anastasia Loktev (A)

Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Heinz Peter Schlemmer (HP)

Division of Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Uwe Haberkorn (U)

Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Nuclear Medicine, University Hospital Heidelberg, Germany; Translational Lung Research Center Heidelberg (TLRC), German Center for Lung Research (DZL), Heidelberg, Germany.

Daniel Paech (D)

Division of Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH